retatrutide peptide trial triples weight loss in obesity | Amr El-Refaey CMI Level 7 Strategic Management Certificate posted on the topic ⚠️ BEWARE OF RETATRUTIDE SOLD
Description
The company is now owned by a private equity firm and operates independently from VillageMD, the primary care chain it once invested billions in
Obesity rates in Canada increased during the pandemic, while at the same time multiple studies have since shown that eating disorders surged
Recent analysis suggests generic versions could reduce medication costs by up to 65 percent once multiple suppliers enter the Canadian market
Semaglutide slows down the rate at which your stomach sends food to your large intestine
In FinnGen, the BMI-related GLP-1R proxy was associated with reduced risks of PTSD, ADHD, BD, alcohol dependence, substance abuse, and MDD
Subsequently, the drug has been approved across the European Union (September 2022), Canada (November 2022), and Australia (December 2022)
